Zhao Y, Ren P, Luo Q, Li X, Cheng X, Wen Y
Front Pharmacol. 2025; 16:1516601.
PMID: 40066336
PMC: 11891183.
DOI: 10.3389/fphar.2025.1516601.
Dai Y, Cui C, Jiao D, Zhu X
Cancer Cell Int. 2025; 25(1):83.
PMID: 40055704
PMC: 11889932.
DOI: 10.1186/s12935-025-03681-6.
Lai S, Ye Y, Ding Q, Hu X, Fu A, Wu L
Front Pharmacol. 2025; 16:1531277.
PMID: 40051561
PMC: 11882853.
DOI: 10.3389/fphar.2025.1531277.
Li J, Li Y, Lai S, Kan X
Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(2):242-247.
PMID: 39962790
PMC: 11838029.
DOI: 10.7499/j.issn.1008-8830.2407062.
Scarpellini C, Klejborowska G, Lanthier C, Toye A, Musialek K, Van San E
J Med Chem. 2025; 68(4):4908-4928.
PMID: 39913870
PMC: 11874020.
DOI: 10.1021/acs.jmedchem.4c03149.
Decoding ferroptosis: transforming orthopedic disease management.
Huo G, Lin Y, Liu L, He Y, Qu Y, Liu Y
Front Pharmacol. 2024; 15:1509172.
PMID: 39712490
PMC: 11659002.
DOI: 10.3389/fphar.2024.1509172.
α-Cyclodextrin/Moringin Induces an Antioxidant Transcriptional Response Activating Nrf2 in Differentiated NSC-34 Motor Neurons.
Gugliandolo A, Cali G, Muscara C, Artimagnella O, Rollin P, Perenzoni D
Antioxidants (Basel). 2024; 13(7).
PMID: 39061882
PMC: 11274022.
DOI: 10.3390/antiox13070813.
Inhibition of FSP1: A new strategy for the treatment of tumors (Review).
Dai Q, Wei X, Zhao J, Zhang D, Luo Y, Yang Y
Oncol Rep. 2024; 52(2).
PMID: 38940330
PMC: 11228423.
DOI: 10.3892/or.2024.8764.
Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer's disease.
Shen Y, Zhang G, Wei C, Zhao P, Wang Y, Li M
Neural Regen Res. 2024; 20(3):613-631.
PMID: 38886929
PMC: 11433915.
DOI: 10.4103/NRR.NRR-D-23-01343.
MiR-122-5p regulates erastin-induced ferroptosis via CS in nasopharyngeal carcinoma.
Guo L, Wang Z, Fu Y, Wu S, Zhu Y, Yuan J
Sci Rep. 2024; 14(1):10019.
PMID: 38693171
PMC: 11063070.
DOI: 10.1038/s41598-024-59080-w.
7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.
Porto Freitas F, Alborzinia H, Dos Santos A, Nepachalovich P, Pedrera L, Zilka O
Nature. 2024; 626(7998):401-410.
PMID: 38297129
DOI: 10.1038/s41586-023-06878-9.
Renal-specific loss of ferroportin disrupts iron homeostasis and attenuates recovery from acute kidney injury.
Soofi A, Li V, Beamish J, Abdrabh S, Hamad M, Das N
Am J Physiol Renal Physiol. 2023; 326(2):F178-F188.
PMID: 37994409
PMC: 11198972.
DOI: 10.1152/ajprenal.00184.2023.
Lipid Quality Control and Ferroptosis: From Concept to Mechanism.
Li Z, Lange M, Dixon S, Olzmann J
Annu Rev Biochem. 2023; 93(1):499-528.
PMID: 37963395
PMC: 11091000.
DOI: 10.1146/annurev-biochem-052521-033527.
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.
Lee J, Roh J
Cell Oncol (Dordr). 2023; 46(6):1605-1623.
PMID: 37438601
DOI: 10.1007/s13402-023-00840-7.
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy.
Wei M, Liu X, Tan Z, Tian X, Li M, Wei J
Front Endocrinol (Lausanne). 2023; 14:1188003.
PMID: 37361521
PMC: 10289168.
DOI: 10.3389/fendo.2023.1188003.
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules.
Xavier da Silva T, Schulte C, Alves A, Maric H, Friedmann Angeli J
Cell Death Dis. 2023; 14(4):281.
PMID: 37080964
PMC: 10119282.
DOI: 10.1038/s41419-023-05787-z.
Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.
Ballout F, Lu H, Chen Z, Hu T, Chen L, Washington M
Antioxidants (Basel). 2022; 11(10).
PMID: 36290582
PMC: 9598457.
DOI: 10.3390/antiox11101859.